Precision BioSciences Receives the 2018 SEBIO Venture Funding Award

DURHAM, North Carolina, USA, November 15, 2018 – Precision BioSciences announced today that it has been recognized as the recipient of the 2018 Southeast BIO (SEBIO) Venture Funding Award. Abid...


Precision BioSciences and MaxCyte Enter into Clinical and Commercial License Agreement

Precision BioSciences is pleased to be working with MaxCyte. Read more about our clinical and commercial license agreement to use the MaxCyte electroporation system for non-viral delivery of genome...


Elo Life Systems Launches Australian Subsidiary in Queensland

RESEARCH TRIANGLE PARK, North Carolina, USA and BRISBANE, Australia, November 5, 2018 – Elo Life Systems has opened a new Australian location at the Queensland University of Technology (QUT),...


Mario G. Pennisi, Australian Life Sciences Industry Leader, Joins Elo-Australia as Resident Director

RESEARCH TRIANGLE PARK, North Carolina, USA and BRISBANE, Australia, October 10, 2018 – Elo Life Systems Inc. announced today that Mario G. Pennisi joined Elo Life Systems as a Resident...


Gilead Sciences and Precision BioSciences Announce Collaboration to Develop Therapies Against Hepatitis B Virus Using ARCUS Genome Editing

FOSTER CITY, Calif. and DURHAM, NC, Sept 12, 2018 – Gilead Sciences (Nasdaq: GILD) and Precision BioSciences announced today that the companies have entered into a strategic collaboration to...


Precision BioSciences Announces Collaboration with University of Pennsylvania to Develop Genome Editing Therapeutics

DURHAM, North Carolina, USA, September 04, 2018 – Precision BioSciences today announced an expansion of their ongoing collaboration with the Gene Therapy Program in the Perelman School of Medicine...


CSO Derek Jantz Discusses Precision's Long History in Genome Editing and the Future of Medicine with PMWC

Precision BioSciences CSO and Co-founder Derek Jantz will present during the Emerging Therapeutics Showcase of the Duke Precision Medicine World Conference (PMWC) on September 25th, 2018 in Durham,...


Penn Announces Publication of Clinically Relevant Genome Editing in Primates Using Precision's ARCUS Platform

Durham, NC July 09, 2018 – The University of Pennsylvania’s Perelman School of Medicine announced today that researchers from Jim Wilson’s Gene Therapy Program have found that using...